164 related articles for article (PubMed ID: 18331259)
1. Therapeutic response after first month of tadalafil treatment predicts 12 months treatment continuation in patients with erectile dysfunction: results from the DETECT study.
Roumeguère T; Verheyden B; Arver S; Bitton A; Belger M; Schmitt H;
J Sex Med; 2008 Jul; 5(7):1708-19. PubMed ID: 18331259
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient expectations and treatment satisfaction after 1-year tadalafil therapy for erectile dysfunction: the DETECT study.
Perimenis P; Roumeguere T; Heidler H; Roos E; Belger M; Schmitt H
J Sex Med; 2009 Jan; 6(1):257-67. PubMed ID: 19170854
[TBL] [Abstract][Full Text] [Related]
3. Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: results from the DETECT study.
Verheyden B; Roumeguère T; Bitton A; Belger M; Schmitt H;
J Sex Med; 2009 Dec; 6(12):3458-68. PubMed ID: 19832933
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
[TBL] [Abstract][Full Text] [Related]
5. Tolerance to the therapeutic effect of tadalafil does not occur during 6 months of treatment: A randomized, double-blind, placebo-controlled study in men with erectile dysfunction.
McMahon CG; Carson CC; Fischer CJ; Wang WC; Florio VA; Bradley JD
J Sex Med; 2006 May; 3(3):504-11. PubMed ID: 16681476
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials.
Rosen RC; Shabsigh R; Kuritzky L; Wang WC; Sides GD
Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689
[TBL] [Abstract][Full Text] [Related]
8. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.
Sharlip ID; Shumaker BP; Hakim LS; Goldfischer E; Natanegara F; Wong DG
J Sex Med; 2008 Mar; 5(3):716-25. PubMed ID: 18304286
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of tadalafil in clinical populations.
Lewis RW; Sadovsky R; Eardley I; O'Leary M; Seftel A; Wang WC; Shen W; Walker DJ; Wong DG; Ahuja S
J Sex Med; 2005 Jul; 2(4):517-31. PubMed ID: 16422847
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
Goldstein I; Kim E; Steers WD; Pryor JL; Wilde DW; Natanegara F; Wong DG; Ahuja S
J Sex Med; 2007 Jan; 4(1):166-175. PubMed ID: 17233782
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of medium and long-term tadalafil use in spinal cord patients with erectile dysfunction.
Lombardi G; Macchiarella A; Cecconi F; Del Popolo G
J Sex Med; 2009 Feb; 6(2):535-43. PubMed ID: 19138363
[TBL] [Abstract][Full Text] [Related]
13. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
Carson C; Shabsigh R; Segal S; Murphy A; Fredlund P; Kuepfer C;
Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052
[TBL] [Abstract][Full Text] [Related]
15. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction.
Porst H; Glina S; Ralph D; Zeigler H; Wong DG; Woodward B
J Sex Med; 2010 Oct; 7(10):3487-94. PubMed ID: 20584129
[TBL] [Abstract][Full Text] [Related]
16. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
Porst H; Gacci M; Büttner H; Henneges C; Boess F
Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses.
Rubio-Aurioles E; Casabé A; Torres LO; Quinzaños L; Glina S; Filimon I; Kopernicky V; Leñero E
J Sex Med; 2008 Aug; 5(8):1965-76. PubMed ID: 18466266
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
[TBL] [Abstract][Full Text] [Related]
19. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
[TBL] [Abstract][Full Text] [Related]
20. Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities.
Hatzichristou D; d'Anzeo G; Porst H; Buvat J; Henneges C; Rossi A; Hamidi K; Büttner H
BMC Urol; 2015 Nov; 15():111. PubMed ID: 26563171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
